We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$17.5B
1-Year Est. Return
50.95%
This Fund
S&P 500
This Quarter
Est. Return
+26.99%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$12.5B
AUM Growth
+$844M
(+7.2%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-12.95%
Top 10 Holdings %
Top 10 Hldgs %
33.14%
Holding
137
New
32
Increased
25
Reduced
37
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$331M |
| 2 |
Aon
AON
|
+$321M |
| 3 |
WUBA
58.com Inc
WUBA
|
+$256M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$217M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.65B |
| 2 |
Cigna
CI
|
+$142M |
| 3 |
Fidelity National Information Services
FIS
|
+$135M |
| 4 |
General Dynamics
GD
|
+$132M |
| 5 |
Wabtec
WAB
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.53% |
| 2 | Communication Services | 18.4% |
| 3 | Technology | 10.42% |
| 4 | Financials | 7.52% |
| 5 | Industrials | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$34.7B
| $539M | 4.31% |
3,796,030
+56,334
| +2% | +$7.63M |
|
|
2
Fidelity National Information Services
FIS
$21.5B
| $481M | 3.85% |
3,590,128
-1,031,080
| -22% | -$135M |
|
|
PPLI
3
People Inc
PPLI
$3.1B
| $456M | 3.65% |
7,889,525
-1,706,599
| -18% | -$75.8M |
|
4
Centene
CNC
$31.3B
| $445M | 3.56% |
7,000,000
-250,000
| -3% | -$16.3M |
|
5
AbbVie
ABBV
$458B
| $407M | 3.26% |
4,150,000
+150,000
| +4% | +$13.2M |
|
6
Thermo Fisher Scientific
TMO
$211B
| $388M | 3.1% |
1,069,505
-173,710
| -14% | -$58.2M |
|
7
Charter Communications
CHTR
$14.7B
| $385M | 3.08% |
755,015
+31,687
| +4% | +$16.1M |
|
|
8
T-Mobile US
TMUS
$193B
| $360M | 2.88% |
+3,457,631
| New | +$331M |
|
9
Visa
V
$677B
| $348M | 2.78% |
1,799,373
+36,105
| +2% | +$6.6M |
|
|
10
Aon
AON
$77.3B
| $331M | 2.65% |
+1,720,498
| New | +$321M |
|
11
Elevance Health
ELV
$81.9B
| $329M | 2.63% |
1,250,000
| – | – |
|
12
Alphabet (Google) Class C
GOOG
$3.9T
| $312M | 2.5% |
4,421,000
-1,482,460
| -25% | -$100M |
|
13
Microsoft
MSFT
$2.84T
| $311M | 2.49% |
1,528,199
-295,521
| -16% | -$53.6M |
|
14
Meta Platforms (Facebook)
META
$1.51T
| $308M | 2.47% |
1,358,494
+270,970
| +25% | +$56.6M |
|
|
INFO
15
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $295M | 2.36% |
3,910,024
-1,015,514
| -21% | -$69.1M |
|
16
Salesforce
CRM
$134B
| $286M | 2.29% |
1,525,648
-88,840
| -6% | -$15M |
|
|
WUBA
17
DELISTED
58.com Inc
WUBA
| $268M | 2.14% |
+4,965,212
| New | +$256M |
|
18
Sherwin-Williams
SHW
$78.3B
| $259M | 2.07% |
1,343,961
-183,429
| -12% | -$33.1M |
|
|
19
Wabtec
WAB
$51.1B
| $249M | 1.99% |
4,325,361
-1,996,993
| -32% | -$113M |
|
20
Exelixis
EXEL
$13.9B
| $243M | 1.95% |
10,250,000
+250,000
| +3% | +$5.79M |
|
|
21
Bristol-Myers Squibb
BMY
$127B
| $213M | 1.71% |
+3,625,000
| New | +$217M |
|
|
XLRN
22
DELISTED
Acceleron Pharma
XLRN
| $200M | 1.6% |
2,100,000
-75,000
| -3% | -$7.23M |
|
23
Alibaba
BABA
$269B
| $200M | 1.6% |
926,700
-196,800
| -18% | -$41M |
|
24
Palo Alto Networks
PANW
$264B
| $196M | 1.57% |
5,112,630
-807,696
| -14% | -$28.5M |
|
25
Equinix
EQIX
$107B
| $188M | 1.5% |
267,597
-14,336
| -5% | -$9.7M |
|
Similar funds
BBA
MCM
LA
CM
ASRS
PP
VMPIC
HNB
Farallon Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Farallon Capital Management held 137 positions worth $12.5B, up 7.2% from $11.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Farallon Capital Management withdrew a net $1.62B in Q2 2020, closing 18 positions and reducing 37 holdings. Its most notable exit was Allergan plc, an estimated $1.65B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 52% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Farallon Capital Management opened a new position in T-Mobile US worth $360M.
- Farallon Capital Management's largest Q2 2020 buy was T-Mobile US: 3,457,631 shares worth $360M.
- Farallon Capital Management added most to Blackstone in Q2 2020, an estimated $125M increase.
- Farallon Capital Management's biggest Q2 2020 reduction was Cigna, cutting an estimated $142M.
- Farallon Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $1.65B.
- Farallon Capital Management's ten largest holdings make up 33% of its $12.5B portfolio in Q2 2020.
- Farallon Capital Management opened 32 new positions and closed 18 in Q2 2020.
- Farallon Capital Management's portfolio value rose 7.2% quarter-over-quarter to $12.5B.
Based on Farallon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.